Parnell Pharmaceuticals
$0.08
0
+$0+0% Monday 20:00
Statistics
Day High
0.17
Day Low
0.17
52W High
0.35
52W Low
0
Volume
300
Avg. Volume
4,927
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
3NovExpected
Expected EPS
0
Actual EPS
0
Financials
-16.19%Profit Margin
Unprofitable24.12MRevenue
-3.91MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PARNF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.
Show more...
CEO
Dr. Alan Richard Bell
Country
AU
ISIN
AU0000XINEU9
Listings
0 Comments
Share your thoughts
FAQ
What is Parnell Pharmaceuticals stock price today?▼
The current price of PARNF is $0.08 USD — it has increased by +0% in the past 24 hours. Watch Parnell Pharmaceuticals stock price performance more closely on the chart.
What is Parnell Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Parnell Pharmaceuticals stocks are traded under the ticker PARNF.
What were Parnell Pharmaceuticals earnings last quarter?▼
PARNF earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Parnell Pharmaceuticals revenue for the last year?▼
Parnell Pharmaceuticals revenue for the last year amounts to 24.12M USD.
What is Parnell Pharmaceuticals net income for the last year?▼
PARNF net income for the last year is -3.91M USD.
In which sector is Parnell Pharmaceuticals located?▼
Parnell Pharmaceuticals operates in the Health Care sector.
When did Parnell Pharmaceuticals complete a stock split?▼
Parnell Pharmaceuticals has not had any recent stock splits.
Where is Parnell Pharmaceuticals headquartered?▼
Parnell Pharmaceuticals is headquartered in Alexandria, AU.